KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 27, 2026 >>  ABB India 6542  [ 3.02% ]  ACC 1142.35  [ -2.14% ]  Ambuja Cements 349.8  [ -3.29% ]  Asian Paints 2290.4  [ -1.40% ]  Axis Bank 1206.2  [ -1.53% ]  Bajaj Auto 10377  [ 2.89% ]  Bank of Baroda 233  [ 0.54% ]  Bharti Airtel 1978  [ 3.18% ]  Bharat Heavy 399  [ 1.27% ]  Bharat Petroleum 295.3  [ 1.83% ]  Britannia Industries 4560  [ -0.22% ]  Cipla 1350  [ -0.22% ]  Coal India 398.7  [ -1.43% ]  Colgate Palm 1605.5  [ -0.71% ]  Dabur India 360  [ 0.28% ]  DLF 670  [ 1.16% ]  Dr. Reddy's Lab. 1305  [ 0.15% ]  GAIL (India) 166  [ -1.19% ]  Grasim Industries 2914.5  [ -1.20% ]  HCL Technologies 1416  [ -0.14% ]  HDFC Bank 680  [ -1.19% ]  Hero MotoCorp 5220.35  [ 0.41% ]  Hindustan Unilever 1820  [ 0.00% ]  Hindalco Industries 893.5  [ 0.51% ]  ICICI Bank 1388.5  [ -0.96% ]  Indian Hotels Co. 812  [ 2.33% ]  IndusInd Bank 831  [ -1.28% ]  Infosys 1161.95  [ -0.26% ]  ITC 260  [ -0.15% ]  Jindal Steel 1060  [ 2.42% ]  Kotak Mahindra Bank 442.85  [ 0.42% ]  L&T 3670  [ -0.19% ]  Lupin 1959.05  [ 0.46% ]  Mahi. & Mahi 2860  [ 0.35% ]  Maruti Suzuki India 11454.85  [ 2.28% ]  MTNL 22.83  [ 0.18% ]  Nestle India 1176  [ 0.68% ]  NIIT 75.72  [ 1.26% ]  NMDC 68.45  [ 2.85% ]  NTPC 303  [ 1.00% ]  ONGC 229  [ 0.33% ]  Punj. NationlBak 121  [ 0.21% ]  Power Grid Corpn. 251.5  [ 1.99% ]  Reliance Industries 1200  [ -0.17% ]  SBI 945.1  [ -1.55% ]  Vedanta 226  [ -0.75% ]  Shipping Corpn. 244.35  [ -0.97% ]  Sun Pharmaceutical 1760  [ 0.98% ]  Tata Chemicals 598.55  [ 0.55% ]  Tata Consumer 999  [ 6.66% ]  Tata Motors Passenge 261.4  [ -0.61% ]  Tata Steel 171.5  [ 1.00% ]  Tata Power Co. 337.45  [ -0.40% ]  Tata Consult. Serv. 2500  [ -1.42% ]  Tech Mahindra 1807  [ 0.50% ]  UltraTech Cement 11195  [ 0.21% ]  United Spirits 1269.65  [ 0.45% ]  Wipro 187  [ -1.06% ]  Zee Entertainment 64.56  [ 0.40% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    DIVI'S LABORATORIES LTD.

    27 October 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE361B01024 BSE Code / NSE Code 532488 / DIVISLAB Book Value (Rs.) 665.36 Face Value 2.00
    Bookclosure 24/07/2026 52Week High 9740 EPS 96.73 P/E 98.26
    Market Cap. 252341.16 Cr. 52Week Low 5648 P/BV / Div Yield (%) 14.29 / 0.32 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Divi's Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Divi's Laboratories Ltd. 2974.00 2793.00 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Divi's Laboratories Ltd. 63.00 154.00 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Divi's Laboratories Ltd. 1108.00 823.00 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Divi's Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Divi's Laboratories Ltd. 891.00 756.00 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Divi's Laboratories Ltd. 53.00 53.00 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Divi's Laboratories Ltd. 37.25 29.46 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Divi's Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Divi's Laboratories Ltd. 29.95 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Divi's Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Divi's Laboratories Ltd. 10388.00 9198.00 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Divi's Laboratories Ltd. 3488.00 2979.00 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Divi's Laboratories Ltd. 506.00 352.00 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Divi's Laboratories Ltd. 3510.00 2929.00 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Divi's Laboratories Ltd. 2607.00 2209.00 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Divi's Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Divi's Laboratories Ltd. 53.00 53.00 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Divi's Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Divi's Laboratories Ltd. 16658.00 14842.00 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Divi's Laboratories Ltd. 0.00 2.00 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Divi's Laboratories Ltd. 3243.00 1927.00 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Divi's Laboratories Ltd. 6520.00 5440.00 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Divi's Laboratories Ltd. 76.00 72.00 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Divi's Laboratories Ltd. 11245.00 10290.00 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Divi's Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Divi's Laboratories Ltd. 33.57 32.38 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Divi's Laboratories Ltd. 25.09 24.01 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Divi's Laboratories Ltd. 98.20 83.21 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Divi's Laboratories Ltd. 15.60 14.83 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Divi's Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Divi's Laboratories Ltd. 173.65 3331.00 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Divi's Laboratories Ltd. 3.47 5.34 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Divi's Laboratories Ltd. 30.00 30.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Shriram Financial Services Private Limited (Formerly known as Way2Wealth Brokers Pvt. Ltd.) - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Shriram Financial Services Pvt. Ltd. (Formerly known as Way2Wealth Brokers Pvt. Ltd.) All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute